25
Participants
Start Date
June 30, 2006
Primary Completion Date
October 31, 2011
Study Completion Date
November 30, 2011
Gemcitabine
1500mg/m2 IV over 150 min IV q 2 weeks 4 months
Erlotinib
150 mg/d Daily, oral 12 months
UPMC Cancer Centers Network, Pittsburgh
Collaborators (1)
Genentech, Inc.
INDUSTRY
Herbert J. Zeh, III MD, FACS
OTHER